Correction: Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer

Genes and Immunity 2026 Open access

Read full text
Authors: Yifei Zhu, Teng Zhou, Yao Zheng, Yanxi Yao, Mingxi Lin, Cheng Zeng, Yuxin Yan, Yifei Zhou, Dou-Dou Li, Jian Zhang
DOI: 10.1038/s41435-025-00374-y
Cited by: 0

Abstract

During a recent internal review of our previously published work—conducted as part of preparations for the next phase of our research—we identified an unintentional duplication in Figure 9H, specifically in the RKO cell line Transwell and Matrigel panels between the shCYP26A1-1 and shCYP26A1-2 groups. This duplication was due to a clerical error during figure assembly, rather than data repetition or manipulation. In the interest of scientific accuracy and transparency, and out of respect for our readers, we have made the following corrections and provided the associated materials.

Fields of Study & Subjects

Colorectal Cancer Treatments and Studies Folate and B Vitamins Research Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Genes and Immunity
Volume
27
Issue
2
Pages
258–259
Publication date
10 February 2026
Language
EN